Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

Presentation CRT 2018

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Presenter: Ron Waksman

March 04, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

Advertisement

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

TCTMD’s Top 10 Most Popular Stories for September 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

High Mortality but Durable Results With Valve-in-Valve TAVR

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content